Liying Ma
High Magnetic Field Laboratory
Hefei, China
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
ARID1A Governs Genomic Stability and Proliferation in SCLC via c-MYC/PARP1 Suppression Driving Vulnerability to BET Inhibitors.
Journal: Research (Washington, D.C.)
Published: May 26, 2025
Interaction and Reciprocal Stabilization of H3.3 and PARP1 Promote DNA Damage Repair and Tumor Progression in Small Cell Lung Cancer.
Journal: Cancer research
Published: November 08, 2024
Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 06, 2021
FK228 sensitizes radioresistant small cell lung cancer cells to radiation.
Journal: Clinical epigenetics
Published: August 25, 2020
The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 29, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026